NDC 68071-3298

Doxazosin

Doxazosin

Doxazosin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Nucare Pharmaceuticals, Inc.. The primary component is Doxazosin Mesylate.

Product ID68071-3298_505d3c4c-5507-72cc-e054-00144ff88e88
NDC68071-3298
Product TypeHuman Prescription Drug
Proprietary NameDoxazosin
Generic NameDoxazosin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2011-07-14
Marketing CategoryANDA / ANDA
Application NumberANDA075580
Labeler NameNuCare Pharmaceuticals, Inc.
Substance NameDOXAZOSIN MESYLATE
Active Ingredient Strength4 mg/1
Pharm ClassesAdrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 68071-3298-3

30 TABLET in 1 BOTTLE (68071-3298-3)
Marketing Start Date2017-05-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68071-3298-6 [68071329806]

Doxazosin TABLET
Marketing CategoryANDA
Application NumberANDA075580
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-05-25

NDC 68071-3298-9 [68071329809]

Doxazosin TABLET
Marketing CategoryANDA
Application NumberANDA075580
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-05-25

NDC 68071-3298-3 [68071329803]

Doxazosin TABLET
Marketing CategoryANDA
Application NumberANDA075580
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-05-25

Drug Details

Active Ingredients

IngredientStrength
DOXAZOSIN MESYLATE4 mg/1

OpenFDA Data

SPL SET ID:505d3c4c-5506-72cc-e054-00144ff88e88
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197627
  • Pharmacological Class

    • Adrenergic alpha-Antagonists [MoA]
    • alpha-Adrenergic Blocker [EPC]
    • Adrenergic alpha-Antagonists [MoA]
    • alpha-Adrenergic Blocker [EPC]

    NDC Crossover Matching brand name "Doxazosin" or generic name "Doxazosin"

    NDCBrand NameGeneric Name
    0093-2067DoxazosinDoxazosin Mesylate
    0093-2068DoxazosinDoxazosin Mesylate
    0093-2069DoxazosinDoxazosin Mesylate
    0093-2070DoxazosinDoxazosin Mesylate
    0378-4021Doxazosindoxazosin mesylate
    0378-4022Doxazosindoxazosin mesylate
    0378-4024Doxazosindoxazosin mesylate
    0378-4028Doxazosindoxazosin mesylate
    0615-5536DoxazosinDoxazosin mesylate
    0615-5537DoxazosinDoxazosin mesylate
    0615-6570DoxazosinDoxazosin mesylate
    0615-6571DoxazosinDoxazosin mesylate
    0832-0356DoxazosinDoxazosin Mesylate
    0832-0357DoxazosinDoxazosin Mesylate
    0832-1358DoxazosinDoxazosin Mesylate
    0832-1359DoxazosinDoxazosin Mesylate
    68071-1889DoxazosinDoxazosin
    68071-4273DoxazosinDoxazosin
    68071-3298DoxazosinDoxazosin
    68071-3331DoxazosinDoxazosin
    68071-3341DoxazosinDoxazosin
    68071-4272DoxazosinDoxazosin
    68084-862DoxazosinDoxazosin
    68084-836DoxazosinDoxazosin
    68084-851DoxazosinDoxazosin
    68382-783DoxazosinDoxazosin
    68382-785DoxazosinDoxazosin
    68382-784DoxazosinDoxazosin
    68382-786DoxazosinDoxazosin
    68645-464DoxazosinDoxazosin
    68645-465DoxazosinDoxazosin
    68645-463DoxazosinDoxazosin
    68788-7149DoxazosinDoxazosin
    68788-7328DoxazosinDoxazosin
    68788-9675DoxazosinDoxazosin
    70518-0839DoxazosinDoxazosin
    70518-1061DoxazosinDoxazosin
    70518-1645DoxazosinDoxazosin
    70518-1560DoxazosinDoxazosin
    70518-1804DoxazosinDoxazosin
    70771-1115DoxazosinDoxazosin
    70771-1114DoxazosinDoxazosin
    70771-1112DoxazosinDoxazosin
    70771-1113DoxazosinDoxazosin
    71335-0309DoxazosinDoxazosin
    71335-0349DoxazosinDoxazosin
    71335-0002DoxazosinDoxazosin
    71610-153DoxazosinDoxazosin
    71610-160DoxazosinDoxazosin
    71610-043DoxazosinDoxazosin

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.